Ticagrelor or Clopidogrel to reduce ischemic events after Percutaneous Coronary Intervention in chronic coronary syndrome in clopidogrel naive patient: the ALPHEUS Naive sub-study

被引：0
|
作者：
Manzo-Silberman, S. [1 ]
Cayla, G. [2 ]
Beygui, F. [3 ]
Range, G. [4 ]
Motovska, Z. [5 ]
Vicaut, E. [6 ]
Collet, J. P. [1 ]
Guedeney, P. [1 ]
El Kasty, M. [7 ]
Kerneis, M. [1 ]
Zeitouni, M. [1 ]
Filippi, E. [8 ]
Coste, P. [9 ]
Montalescot, G. [1 ]
Silvain, J. [10 ]
机构：
[1] Sorbonne Univ, Cardiol, Paris, France
[2] Nimes Caremeau Univ Hosp Ctr, Cardiol, Nimes, France
[3] Univ Hosp Caen, Cardiol, Caen, France
[4] Hosp Louis Pasteur Chartres, Cardiol, Chartres, France
[5] Charles Univ Prague, Cardiol, Prague, Czech Republic
[6] St Louis Univ Hosp, Fernand Widal APHP Site, Methodol & Statist, Paris, France
[7] Hosp Sud Francilien, Cardiol, Corbeil Essonnes, France
[8] Vannes Hosp Ctr Bretagne Atlant, Cardiol, Vannes, France
[9] CHU Bordeaux, Cardiol, Bordeaux, France
[10] Sorbonne Univ, Paris, France
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ticagrelor vs Clopidogrel in Clopidogrel-Naive Patients With Chronic Coronary Syndrome
    Manzo-Silberman, Stephane
    Guedeney, Paul
    Cayla, Guillaume
    Beygui, Farzin
    Range, Gregoire
    Motovska, Zuzana
    Procopi, Niki
    Kerneis, Mathieu
    Zeitouni, Michel
    El Kasty, Mohamad
    Teiger, Emmanuel
    Filippi, Emmanuelle
    Coste, Pierre
    Huchet, Francois
    Cottin, Yves
    Karasek, Jiri
    Arnould, Marc -Antoine
    Braik, Nassim
    Barthelemy, Olivier
    Portal, Jean -Jacques
    Vicaut, Eric
    Montalescot, Gilles
    Silvain, Johanne
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (12) : 1413 - 1421
  • [2] Ticagrelor versus Clopidogrel in Elective Percutaneous Coronary Intervention : The Alpheus Trial
    Silvain, Johanne
    Cayla, Guillaume
    Beygui, Farzin
    Range, Gregoire
    Motovska, Zuzana J.
    Dillinger, Jean Guillaume
    Boueri, Ziad
    Brunel, Philippe
    Lhermusier, Thibault
    Pouillot, Christophe
    Christiaens, Luc
    Boccara, Franck
    Labeque, Jean-Noel
    Georges, Jean-Louis
    Bellemain-Appaix, Anne
    Hauguel-Moreau, Marie
    Le Breton, Herve
    Saint-Etienne, Christophe
    Caussin, Christophe
    Guedeney, Paul
    El Kasty, Mohamad
    Laredo, Mikael Laredo
    Dumaine, Raphaelle
    Ducrocq, Gregory
    Collet, Jean-Philippe
    Lattuca, Benoit
    Blanchart, Katrien
    Kala, Petr
    Vicaut, Eric
    Montalescot, Gilles
    CIRCULATION, 2020, 142 (24) : E485 - E486
  • [3] Ticagrelor versus clopidogrel for complex percutaneous coronary intervention in chronic coronary syndrome: a post-hoc analysis of the ALPHEUS study
    Lattuca, B.
    Mazeau, C.
    Guedeney, P.
    Kala, P.
    Nejjari, M.
    Morel, O.
    Leclercq, F.
    Payot, L.
    Beygui, F.
    Range, G.
    Motovska, Z.
    Vicaut, E.
    Collet, J. P.
    Montalescot, G.
    Silvain, J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [4] Ticagrelor vs Clopidogrel for Complex Percutaneous Coronary Intervention in Chronic Coronary Syndrome
    Lattuca, Benoit
    Mazeau, Cedric
    Cayla, Guillaume
    Ducrocq, Gregory
    Guedeney, Paul
    Laredo, Mikael
    Dumaine, Raphaelle
    El Kasty, Mohamad
    Kala, Petr
    Nejjari, Mohammed
    Hlinomaz, Ota
    Morel, Olivier
    Leclercq, Florence
    Payot, Laurent
    Spaulding, Christian
    Beygui, Farzin
    Range, Gregoire
    Motovska, Zuzana
    Portal, Jean -Jacques
    Vicaut, Eric
    Collet, Jean -Philippe
    Montalescot, Gilles
    Silvain, Johanne
    JACC-CARDIOVASCULAR INTERVENTIONS, 2024, 17 (03) : 359 - 370
  • [5] A Comparative Study on Ticagrelor and Clopidogrel in Patients With Acute Coronary Syndrome Treated With Primary Percutaneous Coronary Intervention
    Wu, Hui
    Jia, Shaobin
    JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 63 (07): : 776 - 783
  • [6] Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
    Turgeon, Ricky D.
    Koshman, Sheri L.
    Youngson, Erik
    Har, Bryan
    Wilton, Stephen B.
    James, Matthew T.
    Graham, Michelle M.
    JAMA INTERNAL MEDICINE, 2020, 180 (03) : 420 - 428
  • [7] Platelet Inhibition with Ticagrelor versus Clopidogrel in Diabetic Patients after Percutaneous Coronary Intervention for Chronic Coronary Syndromes
    Liu, Zhenyu
    Tian, Ran
    Wang, Yang
    Chen, Qian
    Li, Jingyi
    Xu, Lihong
    Zhang, Shuyang
    THROMBOSIS AND HAEMOSTASIS, 2020, 120 (08) : 1221 - 1229
  • [8] EFFECT OF TICAGRELOR AND CLOPIDOGREL ON PLATELET AGGREGATION FUNCTION AFTER PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Sui, Z.
    Qu, P.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (02): : 439 - 445
  • [9] Ticagrelor or prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention for chronic coronary syndromes
    Koshy, Anoop N.
    Giustino, Gennaro
    Sartori, Samantha
    Hooda, Amit
    Feng, Yihan
    Snyder, Clayton
    Dasgupta, Shabitri
    Kumar, Kartik R.
    Krishnamoorthy-Melarcode, Parasuram
    Sweeny, Joseph
    Khera, Sahil
    Serrao, Gregory W.
    Sharma, Raman
    Dangas, George
    Kini, Annapoorna S.
    Mehran, Roxana
    Sharma, Samin K.
    EUROINTERVENTION, 2023, 18 (15) : 1244 - +
  • [10] Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention
    Li, Yuzhuo
    Li, Jing
    Qiu, Miaohan
    Ma, Sicong
    Na, Kun
    Li, Xiaoying
    Qi, Zizhao
    Chen, Sanbao
    Li, Yi
    Han, Yaling
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 : 1395 - 1402
12345